In support of the insufficiency of these canonical pathways of tumor suppression, mice with p53 mutations in the transactivation domain (p5325,26) or in three lysines (p53K117R+K161R+K162R), which lack canonical signaling to initiate cell cycle arrest and apoptosis after DNA damage nevertheless retained tumor suppression [7,8]. The gene discussed is TP53; the disease is neoplasm.